Displaying 1 - 12 of 40
Metabolism, Alcohol & Toxicity

GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session)

Webcasts
View
General Hepatology

Welcome and introduction

Webcasts
View
General Hepatology

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies (Complete Session)

Webcasts
View
General Hepatology

A real-life example of multidisciplinary care: Patient with AATD and metabolic liver disease

Webcasts
View
General Hepatology

Diagnostic testing and monitoring: Patient with AATD-associated lung and liver disease

Webcasts
View
General Hepatology

Future outlook and close (including Q&A)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: Reducing the burden of liver disease - new evidence revealed (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD in Focus: Unveiling Insights from RELIEF Study - Insight from APASL 2024

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic and toxic liver damage in focus - MANPOWER's Latest Breakthroughs Revealed.

Webcasts
View
Metabolism, Alcohol & Toxicity

Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG

Webcasts
View
Displaying 1 - 12 of 40